2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Leukemia
8
Sarcoma
5
Neoplasms
4
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Unspecified Adult Solid Tumor, Protocol Specific
2
Triple Negative Breast Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Melanoma
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Myeloid, Acute
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Erythroblastic, Acute
2
Head and Neck Neoplasms
2
Endometrial Neoplasms
2
Congenital Abnormalities
2
Cholangiocarcinoma
2
Biliary Tract Neoplasms
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Toxoplasmosis
1
Thrombocytosis
1
Testicular Neoplasms
1
Testicular Germ Cell Tumor
1
Recurrence
1
Rectal Neoplasms
1
Interventions
ruxolitinib
4
Specimen Handling
3
Biopsy
3
venetoclax
2
trametinib
1
sonidegib
1
siltuximab
1
regorafenib
1
ponatinib
1
pomalidomide
1
pevonedistat
1
pertuzumab
1
pembrolizumab
1
pelcitoclax
1
peginterferon alfa-2b
1
palbociclib
1
olaparib
1
neratinib
1
luspatercept
1
lorlatinib
1
lenvatinib
1
itacitinib
1
imetelstat
1
idelalisib
1
enzalutamide
1
entrectinib
1
enasidenib
1
durvalumab
1
dehydroftorafur
1
darolutamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thrombocytosis
×
Base Sequence
×
Clear all
NCT06246006
2024-02-07
MPL - NPM
Centre Hospitalier Universitaire de NÄ«mes
Unknown
30 enrolled